ARTHROPLASTY
Lateral femoral cutaneous nerve block does not demonstrate analgesic efficacy in THA
BMC Anesthesiol. 2016 Mar 23;16(1):21120 patients scheduled for total hip arthroplasty were randomized to receive either an ultrasound-guided lateral femoral cutaneous nerve (LFNC) block or placebo, in addition to standard oral paracetamol and ibuprofen, and oxycodone for breakthrough pain. The purpose of this study was to evaluate if the use of a LFCN block significantly reduce pain scores and opioid consumption within the first 24 hours postoperative in comparison to placebo. No significant difference between groups in pain score or opioid consumption were observed.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
